Search
Now showing items 1-3 of 3
Pheroid technology for the topical delivery of depigmenting agents transforming growth factor–ß1 and tumor necrosis factor–a
(North-West University, 2010)
Pigmentation disorders occur in multiple conditions (Hakozaki et al., 2006:105). Although many modalities of treatments are available, none are completely satisfactory (Briganti et al., 2003:101). Two cytokines normally ...
Withania somnifera as a topical anti-melanoma agent
(North-West University (South Africa), 2016)
In recent years people have become more attuned to the use of natural products for medicinal purposes as the belief is that natural products have fewer side effects. While it is true that natural products have medicinal ...
Pheroid technology for the topical delivery of insulin growth factor 1 (IGF-1), keratinocyte growth factor (KGF) and vascular endothelial growth factor (VEGF)
(North-West University, 2009)
The biotechnological era is here and many peptides and proteins are being used as part of
drug therapy. They are, however, not very stable and do not have the physicochemical
properties that allow for oral or topical ...